| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | WO2000006194A9 Depletion of cells responsible for antibody-mediated graft rejection |
| 12/13/2001 | US20010051834 Method for composite cell-based implants |
| 12/13/2001 | US20010051686 For sensitive skin, nonirritating; includes branched or crosslinked polyelectrolyte, comprising a salified strong acid monomer such as 2-acrylamido-2-methylpropanesulfonic acid sodium salt and acrylamide copolymer |
| 12/13/2001 | US20010051656 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction |
| 12/13/2001 | US20010051650 Topical compositions comprising ascomycins |
| 12/13/2001 | US20010051647 A compressed tablet of antibacterial oxazolidinone selected from the group consisting of linezolid, eperezolid and (S)-N-((3-(3-fluoro-4-(tetrahydro-2H-thiopyran-4-yl)phenyl-2-o xo-5-oxazolidinylmethyl)acetamide S,S-dioxide |
| 12/13/2001 | US20010051613 Water solubility |
| 12/13/2001 | US20010051609 Administering Dna |
| 12/13/2001 | US20010051608 Drug delivery |
| 12/13/2001 | US20010051604 Mixture containing stabilizers, sodium chloride, buffer and surfactants |
| 12/13/2001 | US20010051603 Dried blood factor composition comprising trehalose |
| 12/13/2001 | US20010051595 Injection into blood |
| 12/13/2001 | US20010051189 Application of nanoparticles based on hydrophilic polymers as pharamaceutical forms |
| 12/13/2001 | US20010051188 Spheronized beadlets contain didanosine and binder for oral administration; HIV; AIDS |
| 12/13/2001 | US20010051187 Via crystallization upon exposure to pressure; for drug dosage via oral or nasal administration of free-flowing form |
| 12/13/2001 | US20010051186 Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
| 12/13/2001 | US20010051185 Osmotic device containing ranitidine and a prokinetic agent |
| 12/13/2001 | US20010051184 Alcohol solubility |
| 12/13/2001 | US20010051183 Containing antibiotic/anticancer agent entrapped within vesicles; for treatment of breast and colon carcinomas; diagnostics; therapy; biocompatability |
| 12/13/2001 | US20010051182 For treatment of human papilloma virus (warts) without medication by inducing dermatitis |
| 12/13/2001 | US20010051181 Novel formulations for the transdermal administration of asimadoline |
| 12/13/2001 | US20010051180 A pouch containing (a) a transdermal drug delivery device comprising a drug reservoir layer positioned between a release liner and a backing alyer, one of the layer being non-occlusive, (b) oxybutynin as antioxidant and desiccant |
| 12/13/2001 | US20010051176 Conditioned feed formulation comprising a vitamin E or ester liquid absorbed on a support containing a precipitated silica, in the form of a spherical beads and has average bead size in excess of 150 mu m, packed filling density 0.29 |
| 12/13/2001 | US20010051170 Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter |
| 12/13/2001 | US20010051169 Halogenated alkylnyl carbamate and a saturated or unsaturated acylic, cyclic polyol or polyol ether for the treatment of inflammatory and/or desquamating skin disorders associated with Malassezia species; antidandruff agent |
| 12/13/2001 | US20010051166 Hydroxide-releasing agents as skin permeation enhancers |
| 12/13/2001 | US20010051155 Using immunoglobulin binding epitopes |
| 12/13/2001 | US20010051150 Microencapsulated or enteric coated; therapy for kidney diseases |
| 12/13/2001 | US20010051149 System for treating wounds and method for producing this system |
| 12/13/2001 | US20010051140 Method for manufacturing pure guar meal |
| 12/13/2001 | US20010051136 Products and methods for the remineralization and prevention of demineralization of teeth |
| 12/13/2001 | US20010051134 Effervescent vitaceutical compositions and related methods |
| 12/13/2001 | EP1143806A3 Method for increasing pet activity |
| 12/13/2001 | DE10028621A1 Product with core and shell(s), i.e. film tablet, soft capsule or hard capsule empty shell useful in pharmaceuticals, food supplements, foods and cosmetics, comprises shell containing gum arabic |
| 12/13/2001 | DE10025609A1 Transfektionssystem Transfection |
| 12/13/2001 | CA2412386A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization |
| 12/13/2001 | CA2412326A1 Stabilized hmg-coa reductase inhibitor pharmaceutical compositions |
| 12/13/2001 | CA2412197A1 Powder compositions |
| 12/13/2001 | CA2411542A1 Encapsulation of polynucleotides and drugs into targeted liposomes |
| 12/13/2001 | CA2411536A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| 12/13/2001 | CA2411243A1 Use of sulodexide for the treatment of diabetic nephropathy |
| 12/13/2001 | CA2410577A1 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 12/13/2001 | CA2410052A1 Delivery systems for bioactive agents |
| 12/13/2001 | CA2409268A1 Macromolecular drug complexes and compositions containing the same |
| 12/13/2001 | CA2408612A1 Aqueous chondroprotective compositions having defined ph limitations for efficacious delivery |
| 12/13/2001 | CA2408611A1 Kits and methods for optimizing the efficacy of chondroprotective compositions |
| 12/13/2001 | CA2408610A1 Low carbohydrate compositions, kits thereof, and methods of use |
| 12/13/2001 | CA2408609A1 Compositions, kits, and methods for promoting defined health benefits |
| 12/12/2001 | EP1162626A1 Radioactive microsphere and method for preparation thereof |
| 12/12/2001 | EP1161956A1 Medicinal compositions |
| 12/12/2001 | EP1161948A2 Pharmaceutical or food composition for treatment of brain edema |
| 12/12/2001 | EP1161947A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
| 12/12/2001 | EP1161941A1 Quickly disintegrating tablets and process for producing the same |
| 12/12/2001 | EP1161940A1 Tablets and process for producing tablets |
| 12/12/2001 | EP1161547A1 Intravascular delivery of non-viral nucleic acid |
| 12/12/2001 | EP1161410A1 Retinoid antagonists and use thereof |
| 12/12/2001 | EP1161257A2 Pharmaceutical compositions comprising tgf-beta |
| 12/12/2001 | EP1161256A1 Use of nerve growth factor for therapy of intraocular tissue pathologies |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP1161247A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 12/12/2001 | EP1161243A2 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin |
| 12/12/2001 | EP1161241A1 Stable pharmaceutical application form for paroxetin anhydrate |
| 12/12/2001 | EP1161236A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 12/12/2001 | EP1161234A2 Method for delivering benzidine prostaglandins by inhalation |
| 12/12/2001 | EP1161230A1 Transdermal therapy system and method for producing the same |
| 12/12/2001 | EP1161229A1 Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
| 12/12/2001 | EP1161228A2 Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 12/12/2001 | EP1161227A2 Microparticles for delivery of nucleic acid |
| 12/12/2001 | EP1161226A1 Phosphocholine linked prodrug derivatives |
| 12/12/2001 | EP1161225A1 Metered dose inhalers with isobutane as propellant |
| 12/12/2001 | EP1161224A1 Device for releasing cosmetic active substances |
| 12/12/2001 | EP1161221A1 Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use |
| 12/12/2001 | EP1161218A1 Method for making pharmaceutical tablets by compression |
| 12/12/2001 | EP1161145A1 Process for producing granules |
| 12/12/2001 | EP1077688B1 Transdermal therapeutic system containing pergolide |
| 12/12/2001 | EP1032379B1 Composition with azelaic acid |
| 12/12/2001 | EP1009406B1 Pharmaceutical composition for the administration of thiocolchicoside via the buccal mucosa |
| 12/12/2001 | EP0991705A4 Open pore biodegradable matrices |
| 12/12/2001 | EP0981340B1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 12/12/2001 | EP0971708B1 Nimesulide gel systems for topical use |
| 12/12/2001 | EP0941064A4 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS |
| 12/12/2001 | EP0923729B1 Use of a liquid crystalline phase for determining the distribution of a chemical substance between a hydrophobic and a hydrophilic environment |
| 12/12/2001 | EP0907359B1 Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems |
| 12/12/2001 | EP0907358B1 Uniform drug delivery therapy |
| 12/12/2001 | EP0889730B1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 12/12/2001 | EP0879063A4 Preparation and use of magnetically susceptible polymer particles |
| 12/12/2001 | EP0850052B1 Tacrine/selegiline patch |
| 12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
| 12/12/2001 | EP0785802B1 Saponin preparations and use thereof in iscoms |
| 12/12/2001 | EP0782861B1 Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation |
| 12/12/2001 | EP0779805B1 Sustained release of peptides from pharmaceutical compositions |
| 12/12/2001 | EP0766570B1 Methods for treating respiratory disease |
| 12/12/2001 | EP0732923B1 Pharmaceutical compositions containing HIV protease inhibitors |
| 12/12/2001 | EP0730465B1 Use of angiotensin iii and analogs thereof in tissue repair |
| 12/12/2001 | EP0714316B1 Implantable drug delivery means |
| 12/12/2001 | EP0710122B1 Stabilized pharmaceutical peptide compositions |
| 12/12/2001 | EP0671903B1 Topical and transdermal delivery system utilizing submicron oil spheres |
| 12/12/2001 | EP0665743B1 Interdigitation-fusion liposomes and gels |
| 12/12/2001 | EP0655921B1 Novel glucan preparation |